Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-01 06:09 am Purchase | 2025-03-31 | 13G | Clearside Biomedical, Inc. CLSD | Stephen Boyd Wiles | 266,904 5.200% | 266,904 (New Position) | Filing History |
| 2025-03-04 5:20 pm Purchase | 2024-12-31 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 434,901 8.600% | 17,236 (+4.13%) | Filing History |
| 2025-02-21 4:30 pm Purchase | 2024-09-13 | 13D | Clearside Biomedical, Inc. CLSD | Hatteras Venture Advisors IV SBIC, LLC | 20,909 0.400% | 20,909 (New Position) | Filing History |
| 2023-11-01 4:04 pm Purchase | 2023-10-27 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 417,664 10.100% | 16,474 (+4.11%) | Filing History |
| 2023-02-14 10:29 am Sale | 2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD | RTW Investments, LP | 0 0.000% | -253,735 (Position Closed) | Filing History |
| 2023-02-13 12:19 pm Sale | 2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD | Carmignac Gestion | 160,023 3.980% | -48,261 (-23.17%) | Filing History |
| 2023-01-04 4:15 pm Sale | 2022-12-15 | 13D | Clearside Biomedical, Inc. CLSD | Hatteras Venture Advisors III LLC | 243,604 6.100% | -90,724 (-27.14%) | Filing History |
| 2023-01-04 12:06 pm Purchase | 2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 401,190 9.900% | 9,310 (+2.38%) | Filing History |
| 2022-02-14 08:44 am Sale | 2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD | RTW Investments, LP | 253,735 6.400% | -10,141 (-3.84%) | Filing History |
| 2022-02-09 2:09 pm Sale | 2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD | Carmignac Gestion | 208,283 5.200% | -27,781 (-11.77%) | Filing History |
| 2022-01-24 4:03 pm Sale | 2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 391,880 9.900% | -32,466 (-7.65%) | Filing History |
| 2021-02-12 12:25 pm Purchase | 2020-12-31 | 13G | Clearside Biomedical, Inc. CLSD | Carmignac Gestion | 236,064 7.300% | 236,064 (New Position) | Filing History |
| 2021-02-12 09:55 am Purchase | 2020-12-31 | 13G | Clearside Biomedical, Inc. CLSD | RTW Investments, LP | 263,875 8.190% | 13,868 (+5.55%) | Filing History |
| 2021-01-07 11:10 am Purchase | 2021-01-06 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 424,346 11.100% | 61,990 (+17.11%) | Filing History |